Purpose

A randomized controlled trial to determine adherence, acceptability and safety of time restricted eating (TRE) in healthy, sedentary, free-living adults with obesity between the ages of 19-65 years when following 16:8 TRE for 8 weeks. This 9-week study includes a baseline week and 8 weeks of the intervention period. Participants are randomly assigned to the TRE or the non-fasting control group. The TRE group will consume calorie containing food and drink only over an 8 hour period and rest of the 16 hour would be fasting. Adherence to TRE and calorie intake are the primary outcomes. Motivators, facilitators and barriers to TRE, hunger and cravings levels, weight bias internalization, body composition (weight, body fat%, fat mass and muscle mass) , Healthy Eating Index (HEI) to assess diet quality, skin carotenoid levels, disordered eating risk, sleep quality, and perceptions of health and well-being are secondary outcomes.

Condition

Eligibility

Eligible Ages
Between 19 Years and 65 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 19 to 65 years - Owns a smartphone - Apparently healthy - BMI ( more than or equal to 25 kg/m2 ) and high body fat percent (BF%) (≥25% and ≥35% for males and females, respectively) - Sedentary lifestyle (less than 150 minutes of self-reported moderate to vigorous activity per week) - Self-reported eating interval of ≥12 h per day

Exclusion Criteria

  • Diagnosed diabetes mellitus (type I or II), coronary heart disease, heart failure, hypertension, hyperlipidemia, stroke, chronic lung diseases, liver or kidney disease, adrenal diseases, musculoskeletal disorders, uncontrolled thyroid disease (dose changes within the past 3 months), Crohn's disease, Ulcerative Colitis, arthritis, undergoing active cancer treatment except for non-melanoma cancer, uncontrolled psychiatric disorder (a history of hospitalization for psychiatric illness). - Currently taking any medication that is meant for, or has a known effect on, appetite - On anabolic steroid or hormone replacement therapy - Participation in an exercise/nutrition/ weight-loss program within the last 6 months - Any history of surgical intervention for weight management - Having a ≥5% body weight change during the last 3 months - Pregnant or less than 6 months post-partum, breastfeeding, polycystic ovarian syndrome or irregular menstruation - missing limbs, have a pacemaker or metal implants, - eating disorders or EAT-26 score >20 - Alcohol or drug addiction - Current smoker - Works night shifts - Unable to commit to a 9-week study - Not willing to follow study protocol and any other contraindications. - Currently following any of the following restrictive diets - Keto/low carbohydrate/ Vegan/ Vegetarian/ Intermittent fasting/ Paleo/ Calorie restriction/ Any other restrictive diet - Participating in another study

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Time Restricted Eating Group
The TRE group will consume calorie-containing food and drinks only over an 8-hour window between 6 a.m. to 8 p.m. for 8 weeks. During the fasting period, they can take only calorie-free fluids.
  • Behavioral: Time Restricted Eating
    The intervention group will eat and drink in a prescribed daily feeding window of 8-hour between 6 a.m. to 8 p.m. for 8 weeks and follow their normal exercise and resistance training routines. We will allow +/-1 hour starting and ending times for the eating window while aiming for an 8-hour eating window
No Intervention
Control
They will follow their usual eating patterns and consume food over a period of 12 hours or more.

Recruiting Locations

Department of Nutrition and Hospitality Management, University of Mississippi
Oxford, Mississippi 38677
Contact:
Nadeeja N Wijayatunga, MBBS, MPhil, PhD, RDN
662 915 1351
nadeejaw@olemiss.edu

More Details

Status
Recruiting
Sponsor
University of Mississippi, Oxford

Study Contact

Nadeeja N Wijayatunga, MBBS, MPhil, PhD, RDN
662 915 1351
nadeejaw@olemiss.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.